Internal Deadline
Sponsor Deadline
Posted: 4/18/2022

Martin Delaney Collaboratory for Pediatric HIV Cure Research (UM1 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) is soliciting applications to support research on HIV cure in pediatric populations. This FOA will support coordinated basic, clinical, and applied research focused on developing strategies to achieve an HIV cure, defined as either sustained viral remission or eradication of HIV infection. The cure of HIV infection in people living with HIV is one of the highest priorities of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The goal of the Martin Delaney Collaboratory program is to accelerate progress towards developing strategies to achieve either eradication of HIV infection from the body or a sustained viral remission, as defined by sustained viral suppression following cessation of antiretroviral therapy. Funded projects under this FOA will be expected to expand the knowledge base on HIV latency and persistence in pediatric populations, design and evaluate innovative cure strategies, develop and evaluate assays and other modalities to accurately characterize HIV reservoirs and translate findings to the clinical settings. This funding opportunity will target perinatally infected children and adolescents and young adults up to 24 years of age with a primary focus on early treated children.

Companion FOA: RFA-AI-20-035 UM1 Research Project with Complex Structure Cooperative Agreement

Only one application per institution is allowed to either this FOA or RFA-AI-20-035.

Deadlines:

  • Duke Internal: Aug. 28, 2020
  • Letter of Intent Due Date(s): 30 days prior to the application due date

  • AIDS Application Due Date(s): December 7, 2020

RFA-AI-20-036 Expiration Date December 8, 2020

Eligibility Requirements

Only one application per institution (normally identified by having a unique DUNS number or NIH IDF number) is allowed to either this FOA or the companion FOA for the adult Martin Delaney Collaboratories for HIV Cure Research (RFA-AI-20-035) . An institution may not submit one application to this FOA and one application to the adult MDC FOA. However, a given institution may receive funds through subawards from more than one application.

Amount Description

Application budgets are limited to $3.5M in direct costs per year and need to reflect the actual needs of the proposed project.

The total project period must be 5 years.

Internal Nomination

Owing to the sponsor's restriction on the number of applications that may be submitted from Duke, anyone wishing to pursue nomination should submit the following materials as one PDF.

    • NIH Biosketch of PI/PD
    • NIH Project Summary/Abstract (30 lines of text)

Please submit internal materials through My Research Proposal. (Code ILN)  https://www.grantinterface.com/sl/dwtWGP

Instructions for creating an account (if needed) and submitting your materials: https://www.ctsi.duke.edu/myresearchproposal

Amount
$17,500,000
Funding Type
Eligibility
Posted
4/18/2022
Deadline
Internal:
Sponsor: